| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | 2,7 M € | -15.0% | 3,1 M € | +286.0% | -1,7 M € | -156.9% | 3,0 M € | +21.2% | 2,4 M € | -15.6% | 2,9 M € | -1.0% | 2,9 M € | -13.5% | 3,4 M € | +7.3% | 3,1 M € | -1.4% | 3,2 M € | +31.4% | 2,4 M € | -2.1% | 2,5 M € | -3.5% | 2,6 M € | -15.3% | 3,0 M € | -3.7% | 3,2 M € | +57.6% | 2,0 M € | +63.6% | 1,2 M € | +28.4% | 952,5 k € | -12.6% | 1,1 M € | |
| Operating profit | 2,6 M € | -18.3% | 3,1 M € | +285.7% | -1,7 M € | -159.2% | 2,8 M € | +19.2% | 2,4 M € | -17.2% | 2,9 M € | -0.7% | 2,9 M € | -6.9% | 3,1 M € | -0.3% | 3,1 M € | -2.2% | 3,2 M € | +35.3% | 2,4 M € | -4.5% | 2,5 M € | -17.6% | 3,0 M € | +8.0% | 2,8 M € | -1.0% | 2,8 M € | +32.6% | 2,1 M € | +137.6% | 890,9 k € | +10.0% | 809,7 k € | -1.7% | 823,5 k € | |
| Profit/loss | 2,0 M € | -25.4% | 2,7 M € | +225.2% | -2,1 M € | -202.9% | 2,1 M € | +19.0% | 1,7 M € | -13.7% | 2,0 M € | -21.6% | 2,6 M € | +35.2% | 1,9 M € | -4.9% | 2,0 M € | +11.8% | 1,8 M € | +13.2% | 1,6 M € | +18.5% | 1,3 M € | -38.4% | 2,2 M € | +13.5% | 1,9 M € | +6.0% | 1,8 M € | +87.6% | 963,4 k € | +82.9% | 526,8 k € | -16.3% | 629,4 k € | +13.6% | 553,9 k € | |
| Equity | 14,2 M € | +16.4% | 12,2 M € | +28.2% | 9,5 M € | -18.4% | 11,7 M € | +21.7% | 9,6 M € | -9.9% | 10,6 M € | -58.2% | 25,4 M € | +11.3% | 22,8 M € | +9.1% | 20,9 M € | +10.6% | 18,9 M € | +10.5% | 17,1 M € | +10.2% | 15,5 M € | +9.4% | 14,2 M € | +18.1% | 12,0 M € | +19.0% | 10,1 M € | +1214.4% | 768,9 k € | -80.6% | 4,0 M € | +15.4% | 3,4 M € | +22.5% | 2,8 M € | |
| Total assets | 32,0 M € | -14.8% | 37,5 M € | -8.8% | 41,1 M € | +7.4% | 38,3 M € | +40.7% | 27,2 M € | -0.7% | 27,4 M € | -36.2% | 42,9 M € | -8.6% | 47,0 M € | -2.0% | 47,9 M € | +27.5% | 37,6 M € | +20.7% | 31,2 M € | -20.1% | 39,0 M € | +20.0% | 32,5 M € | +4.1% | 31,2 M € | -9.2% | 34,4 M € | -3.1% | 35,5 M € | +100.6% | 17,7 M € | +56.3% | 11,3 M € | +13.3% | 10,0 M € | |
| Cash | 11,6 M € | -36.2% | 18,2 M € | +1.6% | 17,9 M € | -25.4% | 24,0 M € | +67.6% | 14,3 M € | -7.2% | 15,4 M € | -43.5% | 27,3 M € | +5.0% | 26,0 M € | +3183.7% | 792,1 k € | -31.4% | 1,2 M € | -6.4% | 1,2 M € | +29.7% | 950,6 k € | +6.2% | 895,0 k € | -4.3% | 934,8 k € | +12.6% | 830,0 k € | -96.0% | 20,8 M € | +114.6% | 9,7 M € | +179.2% | 3,5 M € | -23.2% | 4,5 M € | |
| Debts | 17,4 M € | -13.8% | 20,2 M € | -23.5% | 26,4 M € | +0.7% | 26,2 M € | +51.4% | 17,3 M € | +5.4% | 16,4 M € | +14.1% | 14,4 M € | -26.3% | 19,5 M € | -3.7% | 20,3 M € | +61.7% | 12,5 M € | +52.7% | 8,2 M € | -58.2% | 19,6 M € | +17.1% | 16,8 M € | -3.0% | 17,3 M € | -28.2% | 24,0 M € | -30.5% | 34,6 M € | +152.1% | 13,7 M € | +74.4% | 7,9 M € | +9.8% | 7,2 M € | |
| Staff | 66,1 | 64,8 | 61 | 60 | 50,6 | 46,3 | 51,2 | 54,3 | 55,1 | 67,7 | 80,6 | 85,2 | 85 | 87 | 78,1 | 57,1 | 38,4 | 32,8 | 37,9 | |||||||||||||||||||
Public limited company · Antwerpen · incorporated on 01/01/1968 · 66,1 ETP
Public limited company profitable and well capitalised. Cash position declining (-36.2%).
Solid counterparty for a standard engagement.
Kenvue Belgium is a Public limited company incorporated in 1968. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Antwerpen. It employs on average 66,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette